HanAll Biopharma Reports Operating Profit of 10 Billion KRW, Up 70% Year-on-Year
[Asia Economy Reporter Minji Lee] HanAll Biopharma announced on the 18th that its operating profit reached 10 billion KRW, a 70% increase compared to the same period last year. Sales increased by 14% to 101.5 billion KRW, while net profit decreased by 49% to 9.9 billion KRW.
Hot Picks Today
![About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]](https://cwcontent.asiae.co.kr/asiaresize/93/2026051416263163580_1778743590.jpg)
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- 1,224th Lotto First Prize: '9, 18, 21, 27, 44, 45'... 2.4 Billion Won Jackpot
- Woman in Her 50s Found Dead 28 Days After Going Missing on Bukhansan Mountain
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
The company stated, "Operating profit increased due to stable sales growth of key products and milestone inflows from clinical development," adding, "The net profit for the previous fiscal year reflected a temporary impact from the issuance of share Earnout by our global partner, Immunovant."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
